Application of GSDMD as biomarker in differential diagnosis and curative effect evaluation of pleural effusion related diseases
A biomarker, pleural effusion technology, applied in the field of differential diagnosis and curative effect evaluation of pleural effusion-related diseases, can solve the problems of low diagnostic sensitivity and poor specificity of tuberculous pleurisy, and achieve the effect of good clinical application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0021] Embodiments of the present invention are described below through specific examples, and those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention can also be implemented or applied through other different specific implementation modes, and various modifications or changes can be made to the details in this specification based on different viewpoints and applications without departing from the spirit of the present invention.
[0022] Pyroptosis is an inflammatory programmed cell death type induced by pathogens and dependent on Caspase-1 or Caspase-11 / 4 / 5 activation, and the N-terminal domain (NT-GSDMD) produced by its lysate GSDMD induces and activates and secretes Two major proinflammatory cytokines: interleukin-1β (IL-1β) and IL-18. GSDMD is a 480 amino acid protein consisting of a C-terminal inhibitory domain and an N-terminal pore-forming domain, which ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap